Deferred Tax Assets, Valuation Allowance of Phio Pharmaceuticals Corp. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Phio Pharmaceuticals Corp. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Phio Pharmaceuticals Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $2,613,000, a 675% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Phio Pharmaceuticals Corp. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,613,000 +$2,276,000 +675% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $337,000 -$2,212,000 -87% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $2,549,000 -$14,386,000 -85% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $16,935,000 +$2,286,000 +16% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $14,649,000 +$4,345,000 +42% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $10,304,000 -$15,328,000 -60% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q4 2019 $25,632,000 +$2,532,000 +11% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $23,100,000 +$2,193,000 +10% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q4 2017 $20,907,000 -$4,621,000 -18% 31 Dec 2017 10-K 27 Mar 2019 2018 FY
Q4 2016 $25,528,000 +$3,633,000 +17% 31 Dec 2016 10-K 26 Mar 2018 2017 FY
Q4 2015 $21,895,000 +$3,960,000 +22% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $17,935,000 +$3,309,000 +23% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q4 2013 $14,626,000 +$11,125,000 +318% 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q4 2012 $3,501,000 +$2,388,000 +215% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q4 2011 $1,113,000 31 Dec 2011 10-K 29 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.